HongKong:0575

Regent Pacific Group Limited Announces the Successful Launch of Fortacin(TM) in Hong Kong, Upcoming Launches in Taiwan and Macau and Related Business Updates

HONG KONG, Jan. 18, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Fortacin™, the Group's ...

2021-01-18 21:21 4397

Regent Pacific Announces Key Research Findings On FORTACIN™

HONG KONG, Jan. 11, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce several key findings on the w...

2021-01-11 23:36 8169

Regent Pacific Announces Key Progresses On FORTACIN(TM) / SENSTEND(TM) - Solution to Premature Ejaculation

CHINA * Regent Pacific received US$0.72 million (approximately HK$5.62 million, (net of 10% PRC withholding tax) from Wanbang Pharmaceutical on29 December 2020 * The Clinical Trial Approval ("CTA") will be obtained from the Center of Drug Evaluation by the end ofQ1 2021 * Regent Pacific to ...

2021-01-04 21:30 11298

Deep Longevity Adds Three Medical Organizations To Its Growing Longevity Network: Healthy Hire Healthy Retire, International Medical Clinics and Peak 1 Wellness

Hong Kong, Dec. 28, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group";SEHK: 0575.HK)'s Deep Longevity, Inc, a company acquired on 14 December 2020 which develops artificial intelligence to track human aging and ext...

2020-12-28 18:47 6080

Deep Longevity Publishes the First Human Psychological Aging Clock Using Artificial Intelligence

HONG KONG, Dec. 17, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK: 0575.HK)'s Deep Longevity, Inc, a company developing artificial intelligence to track human aging and extend productive longevity, releas...

2020-12-17 20:08 9622

Regent Pacific Completes Acquisition of Deep Longevity, Inc

* Expands into the emerging field of artificial intelligence (AI) and longevity medicine * Strengthens shareholder mix by adding experienced longevity and wellness biotechnology investors and entrepreneurs HONG KONG, Dec. 15, 2020 /PRNewswire/ --Regent Pacific Group Limited ("Regent Pacific" ...

2020-12-15 02:03 12508

Regent Pacific's Commercial Strategic Partner Receives Approval from Taiwan Food and Drug Administration

HONG KONG, Dec. 14, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Orient EuroPharma Co., L...

2020-12-14 20:20 3094

Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application

HONG KONG, Dec. 2, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Wanbang Pharmaceutical...

2020-12-02 18:35 9061

Deep Longevity Adds Partnership with My Care Express in Merrillville To Add Biomarkers of Aging and Longevity

HONG KONG, Nov. 26, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK)'s Deep Longevity, Inc, a company subject to a conditional acquisition by the Group which is a pioneer in deep biomarkers of aging...

2020-11-26 16:00 9839

Deep Longevity Launches The First Longevity Medicine Course For Physicians

HONG KONG, Nov. 18, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK)'s Deep Longevity, Inc, a company subject to a conditional acquisition by the Group which is a pioneer in deep biomarkers of aging...

2020-11-18 23:00 8297

Regent Pacific Announces Important Commercialisation Progress On FORTACIN(TM) / SENSTEND(TM)

MAINLAND CHINA * Regent Pacific to receive a total payment of US$4 million upon the receipt of approval from the National Medical Products Administration (NMPA) for conducting human trial * China is expected to be the single largest market for Sendstend™ UNITED STATES * The Phase II valid...

2020-11-17 22:09 2679

Deep Longevity and SquareOne Wellness Partner on Deep Biomarkers of Aging and Longevity

HONG KONG, Oct. 28, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK) today announced that Deep Longevity, Inc, a company recently acquired by the Group which  is a pioneer in deep biomarkers of agin...

2020-10-29 09:57 4354

Deep Longevity and Longenesis to Partner on Consent Management Integration and Federated Learning Method Development

HONG KONG, Oct. 23, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK) today announced that Deep Longevity, Inc,, a company recently acquired by the Group which mainly engaged in the development of ex...

2020-10-23 08:00 9210